The Global Osteoarthritis Therapeutics Market size is estimated to grow from USD 6.9 million in 2022 to USD 10.75 million by 2030. The market is witnessing a healthy CAGR of 5.7% from 2023 to 2030. Growing Adoption of Visco supplementation and an increase in the number of elderly people are the major factors driving the industry's growth.
CLICK HERE To Request Sample PDF
Industry Overview:
In osteoarthritis patients, chondroitin sulfate was once found to appreciably limit aches and enhance hand mobility. The relief of pain and the enchantment of a purposeful reputation are two desires of osteoarthritis treatment. Patients must obtain a mixture of no pharmacologic and pharmacologic therapy to gain fantastic results. Omega-3 fatty acids (fish/krill oil, etc.), glucosamine, chondroitin, vitamins, methylsulfonylmethane (MSM), and natural drug treatments are amongst the dietary supplements most typically used with the aid of Australian and American patients with OA. The SSA acknowledges osteoarthritis as a disability. With osteoarthritis, you can also be eligible for Social Security incapacity benefits. When you practice for incapacity benefits, your analysis and scientific proof to guide it has to healthy a record in the Social Security Administration’s Blue Book. Opioids, oral ache relievers, and parenteral ache relievers are all regularly used to deal with osteoarthritis pain. Alternatives such as orthopedic braces are used as a section of a noninvasive method to ache management, however, due to the ease of administration and affordability of ache medications, ache medicines are broadly used. Oral analgesics (acetaminophen and nonsteroidal anti-inflammatory capsules (NSAIDs) like ibuprofen, naproxen, tramadol, opiates, and duloxetine), topical retailers (like capsaicin and topical NSAIDs), intra-articular sellers (like corticosteroids and hyaluronic acid), and nutraceuticals (glucosamine and chondroitin) are all typically used According to studies, these medicinal drugs can limit continual pain by using 30%. The high cost of the treatment is restraining the growth of the market,
COVID-19 impact on the Osteoarthritis Therapeutics Market
COVID-19 is an infectious ailment caused by the novel coronavirus. Largely unknown before the outbreak started out in Wuhan (China) in December 2019, COVID-19 modified into an international pandemic in no time. The COVID-19 pandemic has expanded the burden on healthcare structures throughout the globe. Companies scaled up R&D efforts to advance vaccines and drugs in opposition to the virus. Throughout the COVID-19 pandemic, sufferers with OA have skilled disruption in access to healthcare services, bad lifestyle habits (increased alcohol consumption and smoking and reduced physical activity), and negative consequences on their standard well-being and intellectual health. The most extraordinarily poor impact was once the cancellation or lengthening of non-compulsory joint substitute surgeries.Although a transient extent in the surgical intervention will no longer end result in sickness progression, immobility due to aches and stiffness can end result in muscle wasting, weight achievement, and diminished excellent of existence. Although patients with extreme OA journey insupportable pain, their signs and symptoms have to now not be left unaddressed. A multimodal strategy in the remedy of OA will drastically enhance signs for the duration of the COVID-19 pandemic and will toughen a subculture of team-based fundamental care in the future. Healthcare companies ought to goal to schedule greater time-honored follow-up appointments by using telemedicine, if possible, to tackle patient needs. Although improved weight and weight problems are related to worse results in sufferers with OA, weight discounts used to be extra difficult during the pandemic due to fewer possibilities for cardio exercise. Adherence to a healthful diet with shut interest in protein necessities ought to be emphasized in the course of follow-up visits. The software efficiently decreased pain, multiplied bodily characteristics and bodily activity, decreased the variety of sufferers taking painkillers, and decreased the number of sufferers on in poor health depart secondary to knee and hip OA.
MARKET DRIVERS:
Growing Adoption of Visco supplementation and an increase in the number of elderly people is driving the growth of the market
Osteoarthritis is related to aging and is extra common amongst humans with different comorbidities such as coronary heart disease, obesity, and diabetes. Life expectancy is developing around the world, which has led to a make bigger in the growing old population. This vogue positively affects the enterprise by growing the incidence of the disorder and developing per capita demand for its remedies. Thus, this getting old population needs excessive therapeutic usage, which enhances the market's growth. Visco supplementation is an advantageous neighborhood osteoarthritis treatment. With the growing prevalence of osteoarthritis and the excessive use of these marketers for pain relief, the market is set to flourish. Moreover, this system relieves stiffness and infection in the bones. Other segments such as analgesics are additionally projected to exhibit an enormous rise in the forecast duration due to these pills being secure and simple. For surgical patients, they provide enormous advantages over centrally performing opioid analgesics and central neuraxial blockade.
MARKET RESTRAINTS:
The lack of skilled workers and the High Cost of treatment is restraining the growth of the market
The lack of qualified personnel who cannot function the redress ought to curb the boom of the world osteoarthritis therapeutics market over a forecast period. The massive expenditure required for the therapy process in phrases of specific antibiotics and surgical operations hampers the market growth.
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2022 - 2030 |
|
Base Year |
2022 |
|
Forecast Period |
2023 - 2030 |
|
CAGR |
5.7% |
|
Segments Covered |
By Type, Application, and Region |
|
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
|
Regional Scope |
North America, Europe, APAC, Latin America, Middle East & Africa |
|
Key Companies Profiled |
Pfizer, Inc., Bayer AG, Horizon Therapeutics PLC, Glaxosmithkline PLC, Anika Therapeutics, Inc., Eli Lilly, Zimmer Biomet Holdings, Inc., Sanofi, Johnson & Johnson, Abbott, Novartis AG, Ferring Pharmaceuticals. |
Segmentation Analysis
Ankle Osteoarthritis
Hip Osteoarthritis
Knee Osteoarthritis
Shoulder Osteoarthritis
Other Anatomies
Based on the Type, Knee osteoarthritis is one of the foremost motives for incapacity at ancient ages in human beings all over the world. According to the article “Global, Regional Prevalence, Incidence and Risk Factors of Knee Osteoarthritis in Population-Based Studies” posted in December 2020, there had been around 654.1 million human beings of age forty years and older residing with osteoarthritis all over the world. As per the equal study, the incidence of osteoarthritis used to be 16% in people aged 15 and was once a 22.9% prevalence rate in human beings of age forty and older. For instance, as per the Eurostat Statistics report’s information posted in June 2021, about 20.6% populace (about one-fifth of the whole population) of Europe used to be of age sixty-five and more, and the share of human beings aged eighty and greater is anticipated to extend by way of two and half of fold, from 5.9% in 2020 to 14.6% in 2022, which will additionally complement the boom of the osteoarthritis therapeutics market.
Hospitals
Clinics
Others
Based on the Application, the hospital segment is estimated to grow at a higher rate due to an increase in the number of people with high knee joint pain and other diseases happenings at the joints which is estimated to drive the growth of the market during the forecast period. The hospital held the biggest segment of the market in 2022 and is further estimated to dominate the market.
North America
Europe
Asia-Pacific
Latin America
The Middle East
Africa
Geographically, the North American market is anticipated to grow, owing to the growing incidence of persistent diseases, the rise in the geriatric population, and modifications in the living existence of people. As a result, the adoption of distinctive remedies and pills is growing in the region. In North America, the United States will keep a considerable share in the osteoarthritis cure market in contrast to Canada and Mexico. According to the file of the National Public Health Agenda for Osteoarthritis 2020 Update by way of the Osteoarthritis Action Alliance, in the United States, osteoarthritis is the most frequent structure of arthritis and influences 1 in 7 adults in the United States, which is about 32.5 million people, from which greater than 50% of adults who are having osteoarthritis are of working age. Additionally, the availability of higher treatment options, authorities' repayment policies, and the growing research and improvement things to do in the improvement of novel therapeutics and the launch of new treatments in the North American vicinity are additionally anticipated to increase the market boom in the region. During the forecasted period, the availability of money for research, a giant affected person population, rising healthcare expenditures, a well-developed healthcare sector, and authorities' assistance for lookup and improvement are predicted to power market growth. Regionally, Europe is divided into There are two kinds of Europe: Western Europe and Eastern Europe. Western Europe controls the majority of the regional market, with Germany, the United Kingdom, and France taking part in important roles. Eastern Europe, on the different hand, is the fastest-growing place due to the extensive untapped market opportunities. The Asia Pacific is the fastest-growing location in the world market due to the presence of a massive variety of patients.
Osteoarthritis Therapeutics Market Share - By Company
Companies like
Pfizer, Inc.,
Bayer AG
Horizon Therapeutics PLC
Glaxosmithkline PLC
Anika Therapeutics
Inc.,
Eli Lilly
Zimmer Biomet Holdings Inc.,
Sanofi
Johnson & Johnson
Abbott
Novartis AG
Ferring Pharmaceuticals
And others are playing an essential role in the market. Mergers and acquisitions in the enterprise have enabled players to diversify and decorate their carrier services. For example, Kitov Pharma Ltd. (Israel) signed an arrangement with Coeptis Pharmaceuticals in 2022, which aided in the effective distribution and commercialization of Consensi.Also, ZILRETTA was approved by the FDA by Flexion Therapeutics, Inc. (US).These businesses are increasing extensively due to ongoing product innovation supported by way of the rapid uptake of modern technologies. In order to feature in the market area effectively, rising companies in the region are focusing on vertical integration of their operations. They are additionally working with familiar manufacturers to enhance their global company presence. Large groups are spending on R&D things to do to create revolutionary items and amplify the utility areas for their products. In addition, the corporations have used other techniques to develop such as mergers and acquisitions.
NOTABLE HAPPENINGS IN THE Osteoarthritis Therapeutics Market IN THE RECENT PAST:
Product Launch - In Nov 2022, Alkem Laboratories launched Ibuprofen and Famotidine tablets, used to relieve the symptoms of rheumatoid arthritis and osteoarthritis in the United States market.
Global automotive lighting refers to all vehicle lighting systems, from headlamps that illuminate the road to taillights that communicate movements. They guarantee motorists and other road users alike safety, visibility, and style. While taillights frequently use LEDs for improved visibility, headlights are available in a variety of technologies, including LED and laser. Interior illumination, DRLs, and signal lights all have a role to play. This market, which was estimated to be worth $33.64 billion in 2022, is anticipated to rise to $67.39 billion by 2030 because of laws, luxury tastes, safety concerns, and technological developments like OLED taillights and adaptive headlights. Anticipate a future dominated by intelligent, connected, personalized, and sustainable lighting systems that enhance the safety, efficiency, and aesthetic appeal of automobiles.
Car lighting works its magic to provide safety, visibility, and style. Headlights cut through the night, taillights express intent, and interiors shine with comfort. The billion-dollar global business is expected to rise due to consumer demand for high-end experiences, safer roads, and cutting-edge technology. Imagine dynamic messages being painted by taillights, headlights that adjust to the road, and interiors that customize their atmosphere. Driven by technological advancements like linked systems and laser beams, this future is calling. Anticipate even more visually attractive, environmentally friendly, and intelligent lighting to illuminate the way ahead, making cars safer, more efficient, and unquestionably cooler.
In the market for automobile lighting, safety is the driving force behind demand from the public and laws. While automated high beams smoothly react to traffic, adaptive headlights modify their beams so as not to blind other people. With visually striking displays, dynamic taillights convey intentions for braking and turning. Beyond these developments, integrated pedestrian identification and lane departure alerts will soon make roads safer and brighter for everyone.
Luxurious automobile lighting creates a distinct visual identity that goes beyond simple illumination. Personalized interior lighting customizes the driving experience by setting the mood with a range of colours and intensities, while intricate designs and distinctive DRLs modify exteriors. As you approach your automobile at night, welcoming lights lead the way, resulting in an interior that is perfectly lit. Not only is this symphony of light aesthetically pleasing, but it also stands as a tribute to luxury. Upcoming developments like gesture-controlled lighting and holographic displays promise to further enhance the experience.
The worldwide automotive lighting market is undergoing a significant transition towards energy-efficient solutions, as environmental concerns gain prominence. LED technology is leading the way, providing a ray of hope for the environment and drivers alike. LED lights beam brighter and use a lot less energy than conventional halogen lamps. There are some tangible advantages to this. For drivers, this translates to increased fuel economy, which lowers petrol prices and lessens reliance on fossil fuels. Greater air quality and a reduction in the transport sector's contribution to climate change are the results of reduced overall emissions.
Although the global automotive lighting business is booming, there are still unknowns. Difficulties impede growth even as innovation propels it with eye catching features like laser beams and adaptable headlights. These technologies are luxury items due to their high cost and difficult integration, which puts producers' abilities to the test. The worldwide patchwork created by unclear legislation limits the potential of innovation. Durability issues persist, particularly when complex systems are subjected to challenging conditions. Ultimately, a lot of drivers still don't fully understand how these improvements can help them. Together, we can overcome these obstacles. The keys to reducing costs are improved production, more seamless integration, and unified regulations. Their full potential can be realized by educating customers about the safety, efficiency, and aesthetic value of these lighting wonders. By working together, we can pave the way for an even brighter and safer future for vehicle lighting.
It is made possible by advanced LED technology, which gives drivers the ability to customize their illumination for the highest level of comfort and flair. Consumers that care about the environment want greener products, and vehicle lighting complies. While solar- and self-powered lighting technologies offer a future powered by clean energy, energy-efficient LEDs lower pollution. The advent of connected lighting systems heralds a new age. Envision automobiles interacting with infrastructure and one another to minimize accidents and enhance traffic efficiency. Integrated headlights with pedestrian recognition provide unmatched safety, while dramatic taillights with eye-catching displays alert onlookers to your intentions. The possibilities are endless in the future. Gesture-controlled interior illumination, holographic displays projected onto the road, and even light fixtures with self-healing capabilities.
Due to laws requiring safety features like headlights, taillights, and brake lights, exterior lighting presently holds the most market share in the vehicle lighting industry. The dominance of this market is partly attributed to advancements in safety-focused technologies such as adaptive headlights and daytime running lights. The market value of external lighting is increased by the quick adoption of technology like LED bulbs and laser lights, which improve performance and aesthetics. Conversely, the interior lighting market is expected to increase at the fastest rate in the upcoming years. Innovations like ambient lighting and technology breakthroughs like LED and OLED displays, driven by consumer demand for comfort and personalisation, open new possibilities. The spread of sophisticated interior lighting systems is further driven by the growing emphasis on safety and the expansion of the luxury car market.
The worldwide vehicle lighting market is currently dominated by halogen because of its more affordable price, advanced technology, and useful illumination. With its dependable supply chain and affordable option for manufacturers and cost-conscious customers, halogen holds the biggest market share. The fastest-growing market right now is LEDs, which are predicted to shortly overtake halogen. The rapid expansion of LEDs is driven by their higher efficiency, longer lifespan, flexibility in design, and technological breakthroughs including enhanced brightness. Because LEDs use less energy and produce fewer emissions and better fuel economy, they are becoming more and more popular in the changing automotive lighting market.
Passenger automobiles rule the worldwide automotive lighting market. The sheer number of passenger cars produced which surpasses that of business vehicles and fuels the need for lighting systems is the primary cause of this popularity. The growing demand for personal automobiles in developing nations is a result of rising disposable income, which in turn drives the rise of the passenger car market. The importance that consumers place on safety and aesthetics elements helps to drive market expansion. But in the upcoming years, the market for electric and hybrid cars is expected to develop at the quickest rate. The exponential rise of the worldwide electric car market, which is still expanding and shows no signs of slowing down, is what is driving this surge. Specialised lighting solutions are required since electric and hybrid vehicles have different lighting requirements because of their specific functionality and design aesthetics.
Most lighting systems sold nowadays are sold by OEMs (Original Equipment Manufacturers), primarily because manufacturers pre-install lighting systems in new cars. But in the next years, the aftermarket is expected to develop at the quickest rate. This spike in demand for replacement parts, especially lighting systems, can be linked to several variables, one of them being the average age of cars. The industry is expanding because of consumers' growing desire to personalise their cars with aftermarket lighting upgrades such LED upgrades and decorative lighting. The availability and affordability of technologies like adaptive headlights and laser lights in the aftermarket, together with other advancements in lighting technology, are driving demand even more. Moreover, the growing market for electric cars (EVs).
Throughout the forecast period, Asia Pacific is anticipated to be the automotive lighting market with the highest profitability. Over the past few years, Asia Pacific countries like China and India have seen notable increases in automotive manufacturing and sales, primarily in the medium-to premium luxury car segment. Asia Pacific is predicted to see an increase in the manufacturing of passenger cars, with India experiencing the strongest growth rate. Depending on the state of the national economy, the area offers a suitable selection of both high-end and cheap cars. For instance, there is a substantial demand for halogen, Xenon/HID, and LED since China and India produce more economy and mid-range automobiles. On the other hand, luxury car adoption rates are greater in South Korea and Japan, where LED lighting is the norm.
A brief shadow was thrown by COVID-19 over the worldwide automotive lighting market. Production was stopped by lockdowns and supply chain disruptions, while luxury lighting upgrades were shelved by consumers on a tight budget. Resources became scarce, and R&D stagnated. Still, the market is recovering thanks to resurgent demand and rearranged priorities. While energy-efficient LEDs are being pushed towards adoption by sustainability, safety concerns are driving interest in features like pedestrian detection and adaptive headlights. The digital push of the epidemic creates opportunities for intelligent, networked lighting systems that may interact with infrastructure and other cars. Ultimately, the industry is positioned to shine brighter, focused on safety, sustainability, and a connected future, even though the pandemic dimmed its brilliance.
A development collaboration between OSRAM Continental and REHAU aims to incorporate lighting into external components, providing automobile manufacturers with innovative lighting options that improve functionality and design flexibility. For rear combination lamps, Hella unveiled a revolutionary lighting innovation called Hella FlatLight technology. A Memorandum of Understanding (MoU) was signed by Samvardhana Motherson Automotive Systems Group BV (SMRPBV), a division of Motherson Group, and Marelli Automotive Lighting to investigate a technology collaboration focused on intelligently lighted external body components. Valeo debuted their revolutionary 360° lighting system at the Shanghai Auto Show. This technology surrounds the car with a band of light, projecting instantaneous, clear signs that other drivers can see from a distance. Pedestrians, cyclists, and scooter riders are especially susceptible to these signals
The Global Osteoarthritis Therapeutics Market size is estimated to grow from USD 6.9 million in 2022 to USD 10.75 million by 2030. The market is witnessing a healthy CAGR of 5.7% from 2023 to 2030.
The Osteoarthritis Therapeutics Market drivers are the Growing Adoption of Visco supplementation and an increase in the number of elderly people.
The Segments under Osteoarthritis Therapeutics Market segments by Application are Hospitals, Clinics, and others.
North America is the most dominating region in the Osteoarthritis Therapeutics Market.
Pfizer, Inc., Bayer AG, and Horizon Therapeutics PLC are the leading players in the Osteoarthritis Therapeutics Market.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
Specify your preferred Countries, Segments, or timeframes
Unlock Country Level Outlook, Trends, Cross-country Comparability, or supply Chain Variations.
Analyst Support
Every order comes with Analyst Support.
Customization
We offer customization to cater your needs to fullest.
Verified Analysis
We value integrity, quality and authenticity the most.
